‹ All episodes

The BioInsights Podcast

Multiomics integration: advancing pediatric cancer immunotherapy

November 02, 2023 BioInsights
The BioInsights Podcast
Multiomics integration: advancing pediatric cancer immunotherapy
Chapters
Chapters
1:02
Can you tell us a bit about your current role and the work that you do?
1:52
Could you tell us more about how you apply these multiomic approaches in your work and what the cutting edge in the area is for you?
4:44
What impact are these tools having on our understanding of the immune response/immunotherapy approaches to cancer?
9:42
What progress do you see being made in the ongoing search for novel biomarkers in the I-O space, and what will be the keys to their successful deployment?
11:40
What should be the next specific targets for the oncology field in terms of further improving our knowledge of the underlying biology of the immune response/tumor microenvironment? What tools will be key in achieving success in these efforts?
13:04
What would be top of your wish list for new innovations in this space?
15:57
What will be your own key goals and priorities in the next few years?
Info
The BioInsights Podcast
Multiomics integration: advancing pediatric cancer immunotherapy
Nov 02, 2023
BioInsights

Lauren Coyle, Editor, Immuno-Oncology Insights, speaks with Raoul Santiago, Clinical Investigator and Associate Professor of Pediatric Hematology and Oncology, University Hospital Center, Laval University, to discuss the role of multiomics in the I-O setting and how these tools can be leveraged to improve pediatric cancer care.

Share
Apple Podcasts Spotify Amazon Music Overcast Castro Castbox +
Show Notes Chapter Markers

Lauren Coyle, Editor, Immuno-Oncology Insights, speaks with Raoul Santiago, Clinical Investigator and Associate Professor of Pediatric Hematology and Oncology, University Hospital Center, Laval University, to discuss the role of multiomics in the I-O setting and how these tools can be leveraged to improve pediatric cancer care.

1:02
Can you tell us a bit about your current role and the work that you do?
1:52
Could you tell us more about how you apply these multiomic approaches in your work and what the cutting edge in the area is for you?
4:44
What impact are these tools having on our understanding of the immune response/immunotherapy approaches to cancer?
9:42
What progress do you see being made in the ongoing search for novel biomarkers in the I-O space, and what will be the keys to their successful deployment?
11:40
What should be the next specific targets for the oncology field in terms of further improving our knowledge of the underlying biology of the immune response/tumor microenvironment? What tools will be key in achieving success in these efforts?
13:04
What would be top of your wish list for new innovations in this space?
15:57
What will be your own key goals and priorities in the next few years?